维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="Faber AC"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors显示文摘	Faber AC Corcoran RB Ebi H	2011	Cancer Discov2011，1，4：	1
2	Acquired resistance to EGFR tyro- sine kinase inhibitors in cancer cells is mediated by loss of IGF-bind- ing proteins 显示文摘	Guix M Faber AC Wang SE	2008	J Clin Invest2008，118，：	1
3	Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3Kinhibition显示文摘	Faber AC Li D Song Y		0，，：	1
4	Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins显示文摘	Guix M Faber AC Wang SE	2008	J Clin Invest2008，118，7：	1
5	Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins显示文摘	Guix M Faber AC Wang SE		0，，07：	1
6	PI3K Regulates MEK/ERK signaling in breast cancer via the Rac-GEF,P-Rex1显示文摘	Ebi H Costa C Faber AC Nishtala M Kotani H Juric D	2013	Proc Natl Acad Sci USA2013，110，21：	1
7	An ErbB3 antibody,MM-121,is active in cancers with ligand-dependent activation显示文摘	Schoeberl B Faber AC Li D	2010	Cancer Res2010，70，6：	1
8	An ErbB3 antibody,MM-121,is active in cancers with ligand-dependent activation显示文摘	Schoeberl B Faber AC Li D		0，，6：	1
9	Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition显示文摘	Faber AC Li D Song Y	2009	Proc Natl Acad Sci U S A2009，106，19：	1
10	Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediat-ed by loss of IGF-binding proteins显示文摘	Guix M Faber AC Wang SE	2008	J Clin Invest2008，118，7：	1
11	Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is media- ted by loss of IGF-binding proteins 显示文摘	Guix M Faber AC Wang SE	2008	J Clin Invest2008，118，7：	1
12	BIM expression in treatment -naive cancers predicts responsiveness to kinase inhibitors 显示文摘	Faber AC RB Corcoran H Ebi	2011	Cancer Discovery2011，1，4：	1
13	roTOR Inhibition Specifically Sensitizes Colorectal Cancers with KRAS or BRAF Mutations to BCL-2/BCL-XL Inhibition by Supressing MCL-1 显示文摘	Faber AC Coffee EM Costa C	2014	Cancer discov2014，4，1：	1
14	Ion concentration ad- jacent to glass-ionomer restorations in primary molars 显示文摘	Bezerra AC Novaes RC Faber J	2012	Dent Mater2012，28，11：	1
15	Acquired resistance to EGFR tyrot sine kinase inhibitors in cancer ceils is mediated by loss of IGF-~ binding proteins显示文摘	Guix M Faber AC Wang SE	2008	J Clin Invest2008，118，7：	1
16	An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation 显示文摘	Schoeberl B Faber AC Li D	2011	Cancer Res2011，70，6：	1
17	Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF?binding proteins显示文摘	Guix M Faber AC Wang SE	2008	J Clin Invest2008，118，7：	1
18	Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition显示文摘	Faber AC Li D Song Y	2009	Proc Nail Aead Sci U S A2009，106，19：	1
19	Acquired resistance toEGFR tyrosine kinase inhibitors in cancer cells is mediat- ed by loss of IGF-binding proteins 显示文摘	Guix M Faber AC Wang SE	2008	J Clin Invest2008，118，7：	1
20	PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF,P-Rexl显示文摘	Ebi H Costa C Faber AC	2013	Proc Natl Acad Sci USA2013，110，21：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示